Ten X Genomics Stock Surges, But Long-Term Challenges Persist
Update: 2025-11-11
Description
Ten X Genomics stock surges after Canaccord Genuity raises target price, following better-than-expected earnings. Despite recent gains, long-term investors still face challenges, as shares bought five years ago are now worth less than half their initial value.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
